ASSOCIATION BETWEEN AFFECTIVE DISORDERS AND THE USAGE OF LOW AND MEDIUM DOSES OF CORTICOSTEROIDS

It is well known that high doses of corticosteroids can induce psychiatric disorders, especially the maniacal states. However there are only a few studies that investigate the effects of low and medium doses of such drugs used for a long period of time on the patient’s mental health. The aim of the study was to investigate the prevalence and severity of affective disorders among the patients using up to 40 mg of corticosteroids (prednisone or equivalent). 54 patients during the corticosteroid therapy and 51 healthy controls were assessed with the use of the following questionnaires: Hypomania Checklist 16 (HCL-16), Beck Depression Inventory (BDI) and authors’ questionnaire. The results were analysed using SPSS Statistics version 12.5. The results indicated statistically significant differences in the prevalence of hypomania and depression between controls and study group. There were no evident correlations between either the dose or the length of the therapy and the severity of affective disorders. The study has shown that the usage of corticosteroids doses below 40 mg does have an effect on the prevalence of affective disorders. The occurrence of hypomania and depression was more common among the study group. To assess correlations further studies are needed

ASSOCIATION BETWEEN DEPRESSION AND HEMODIALYSIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Depression is the most common and serious psychiatric disorder that affects patients with chronic kidney disease and end-stage renal disease, and, has a significant impact on their quality of life. The aim of this study was to investigate and compare prevalence rates of depression among hemodialyzed patients, and non-dialyzed patients with a glomerular filtration rate <30 ml/min/1.73m2 receiving conservative treatment or following kidney transplantation. A total of 50 hemodialyzed and 50 non-dialyzed patients with stage 4/5 of CKD was assessed using the following questionnaires: Hamilton Anxiety Rating Scale (HAM-A), Hamilton Depression Rating Scale (HAM-D), The Satisfaction with Life Scale (SWLS), The Acceptance of Illness Scale (AIS), and The Life Orientation Test-Revised (LOT-R). The use of steroids and immunosuppressant drugs was also investigated. Symptoms of depression and anxiety were present in both groups, however the proportion of persons with mild or severe depression was higher among dialyzed patients. The AIS, LOT-R and SWLS scores were very similar in both the groups. The patients using steroids and/or immunosuppressant drugs were more prone to develop mild or severe depression according to the HAM-D scores. The results indicated a high prevalence of depression and anxiety among patients with CKD. Furthermore, the fraction of patients with depression is greater among hemodialyzed patients. This indicates the importance of monitoring the mental state of the patients as well as the necessity of providing timely psychological care for patients with CKD

ASSOCIATION BETWEEN AFFECTIVE DISORDERS AND THE USAGE OF LOW AND MEDIUM DOSES OF CORTICOSTEROIDS

It is well known that high doses of corticosteroids can induce psychiatric disorders, especially the maniacal states. However there are only a few studies that investigate the effects of low and medium doses of such drugs used for a long period of time on the patient’s mental health. The aim of the study was to investigate the prevalence and severity of affective disorders among the patients using up to 40 mg of corticosteroids (prednisone or equivalent). 54 patients during the corticosteroid therapy and 51 healthy controls were assessed with the use of the following questionnaires: Hypomania Checklist 16 (HCL-16), Beck Depression Inventory (BDI) and authors’ questionnaire. The results were analysed using SPSS Statistics version 12.5. The results indicated statistically significant differences in the prevalence of hypomania and depression between controls and study group. There were no evident correlations between either the dose or the length of the therapy and the severity of affective disorders. The study has shown that the usage of corticosteroids doses below 40 mg does have an effect on the prevalence of affective disorders. The occurrence of hypomania and depression was more common among the study group. To assess correlations further studies are needed

ASSOCIATION BETWEEN DEPRESSION AND HEMODIALYSIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Depression is the most common and serious psychiatric disorder that affects patients with chronic kidney disease and end-stage renal disease, and, has a significant impact on their quality of life. The aim of this study was to investigate and compare prevalence rates of depression among hemodialyzed patients, and non-dialyzed patients with a glomerular filtration rate <30 ml/min/1.73m2 receiving conservative treatment or following kidney transplantation. A total of 50 hemodialyzed and 50 non-dialyzed patients with stage 4/5 of CKD was assessed using the following questionnaires: Hamilton Anxiety Rating Scale (HAM-A), Hamilton Depression Rating Scale (HAM-D), The Satisfaction with Life Scale (SWLS), The Acceptance of Illness Scale (AIS), and The Life Orientation Test-Revised (LOT-R). The use of steroids and immunosuppressant drugs was also investigated. Symptoms of depression and anxiety were present in both groups, however the proportion of persons with mild or severe depression was higher among dialyzed patients. The AIS, LOT-R and SWLS scores were very similar in both the groups. The patients using steroids and/or immunosuppressant drugs were more prone to develop mild or severe depression according to the HAM-D scores. The results indicated a high prevalence of depression and anxiety among patients with CKD. Furthermore, the fraction of patients with depression is greater among hemodialyzed patients. This indicates the importance of monitoring the mental state of the patients as well as the necessity of providing timely psychological care for patients with CKD